Clinical Trials at Mayo Clinic in Arizona
As of September 2026, 66 paid clinical trials are recruiting at Mayo Clinic in Arizona, located at 13400 E SHEA BLVD, SCOTTSDALE, AZ 85259-5404, phone (480) 301-8000 in Scottsdale, Arizona. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Advanced Solid Tumor and Hematopoietic and Lymphatic System Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
66 clinical trials at Mayo Clinic in Arizona
·Clear filters·Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Pulmonary Rehabilitation for Rural Patients With COPD
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Growth Hormone for the Treatment of Gastroparesis
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
Common conditions studied in Scottsdale
- Malignant Solid Neoplasm (12 active studies)
- Advanced Solid Tumor (9 active studies)
- Cancer (9 active studies)
- Hematopoietic and Lymphatic System Neoplasm (9 active studies)
- Breast Cancer (8 active studies)
- Solid Tumor (8 active studies)
Leading research sponsors in Scottsdale
- Mayo Clinic
- Eli Lilly and Company
- Pfizer
- Sanofi
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Scottsdale?
There are approximately 393 recruiting clinical trials in Scottsdale, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scottsdale pay participants?
Most recruiting trials in Scottsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scottsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scottsdale?
The most common conditions under active study in Scottsdale include Malignant Solid Neoplasm (12), Advanced Solid Tumor (9), Cancer (9), Hematopoietic and Lymphatic System Neoplasm (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scottsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scottsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scottsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scottsdale?
Recruiting research sites in Scottsdale include Mayo Clinic in Arizona, Mayo Clinic Arizona, HonorHealth Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scottsdale right now?
The largest active categories in Scottsdale are Cancer & tumors (129), Neurology & pain (26), Cardiovascular (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Mayo Clinic in Arizona?
Mayo Clinic in Arizona is located at 13400 E SHEA BLVD, SCOTTSDALE, AZ 85259-5404. Use the Google Maps link in the intro above to get directions.
How do I contact Mayo Clinic in Arizona?
You can reach Mayo Clinic in Arizona by phone at (480) 301-8000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.